CCL2 and coronary artery disorder: The plasma concentrations of monocyte chemoattractant protein 1 (MCP1) in CD14+ monocytes from coronary heart disease patients were significantly upregulated, and the H3K9 tri-methylation of the MCP1 promoter was decreased [67].